Physician

Jonathan Medenilla Zuniga, M.D.

According to 2025 Medicare claims, Jonathan Zuniga, M.D. (NPI: 1831167212) practices nephrology in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Putnam, WV. This provider's primary affiliated billing organization is KIDNEY ASSOCIATES PLLC (NPI: 1730391731; TIN: 03-0458885) and primary practice location at 25526-9622. Zuniga is affiliated with the ACO West Virginia (ACO ID: A3563) and Vandalia Health Network (ACO ID: A4513), participating under the MSSP model.

Zuniga's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 549 traditional Medicare patients, billed 3,757 HCPCS/CPT codes, and received $272,032 in Medicare payments. The top billing code was 93975 (Complete ultrasound of abdomen and pelvis artery and vein blood flow). Part D data shows 2,760 prescription claims across 489 beneficiaries totaling $232,620 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). Open Payments data shows 2 records totaling $36. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $304,902 and ending at $232,620. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	620	42,471	$341,667
2016	729	40,720	$368,170
2017	841	29,289	$537,195
2018	846	8,736	$422,047
2019	854	5,775	$454,973
2020	617	5,234	$404,414
2021	604	4,591	$353,829
2022	624	4,864	$352,297
2023	554	3,839	$289,032
2024	549	3,757	$272,032

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	473	3,259	$304,902
2016	447	2,978	$329,446
2017	453	2,733	$297,921
2018	412	2,489	$167,868
2019	422	2,548	$202,545
2020	396	2,439	$211,695
2021	382	2,231	$296,417
2022	394	2,218	$221,808
2023	486	2,752	$258,857
2024	489	2,760	$232,620

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93975	Complete ultrasound of abdomen and pelvis artery and vein blood flow	175	218	$121
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	244	292	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	252	484	$80
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	278	2,198	$55
76770	Complete ultrasound scan behind abdominal cavity	169	211	$39

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	49	2,610	$160,868
Calcitriol	Calcitriol	704	31,711	$11,469
Sevelamer Carbonate	Sevelamer Carbonate	66	3,720	$9,256
Torsemide	Torsemide	224	10,629	$3,222
Furosemide	Furosemide	390	23,103	$2,172

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$36	OPKO Pharmaceuticals, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jonathan Medenilla Zuniga, M.D.?

Tedicare shows public-source Medicare data for Jonathan Medenilla Zuniga, M.D. (NPI 1831167212), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan Medenilla Zuniga, M.D. have ACO affiliation data?

Jonathan Medenilla Zuniga, M.D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563) and Vandalia Health Network (MSSP, ACO ID A4513).

What billing organization is linked to Jonathan Medenilla Zuniga, M.D.?

Jonathan Medenilla Zuniga, M.D. is linked to KIDNEY ASSOCIATES PLLC (billing NPI 1730391731) in the available physician profile data.

Does Jonathan Medenilla Zuniga, M.D. have Open Payments data?

Jonathan Medenilla Zuniga, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.